EQT and KKR announce that EQT VIII fund (“EQT”) has agreed to sell Karo Healthcare (“Karo” or the “Company”) to KKR. Karo is a leading pan-European consumer healthcare company headquartered in Stockholm, Sweden. The Company operates an attractive product portfolio spanning core categories such as Skin Health, Foot Health, and Intimate Health, as well as Digestive Health and Vitamins, Minerals & Supplements. Under EQT’s ownership since 2019, Karo has undergone a significant strategic repositioning, shifting from a specialty pharmaceutical company focused on the Nordics into becoming a pan-European pure-play consumer healthcare platform.
Read the full article: EQT to Sell Karo Healthcare, a Leading Pan-European Consumer Health Platform, to KKR //
Source: https://www.prnewswire.com/news-releases/eqt-to-sell-karo-healthcare-a-leading-pan-european-consumer-health-platform-to-kkr-302424403.html